Redeye lowers its short-term expectations on Strax due to the corona-crisis. Our long-term view of the case remains optimistic, with an experienced team managing the business and a vast distribution network providing a competitive edge. On the back of a solid Q4'19-report and a share price decline of 50% during March, we identify an attractive opportunity for the long-term investor.